European Society of Toxicology In Vitro > Uncategorized > ESTIV welcomes two new corporate members!
26 July 2021

ESTIV welcomes two new corporate members!

React4life is an Italian startup that developed MIVO® – Multi In Vitro Organ, a patented microphysiological system (MPS) able to reproduce portions of the human body improving the reliability of the testing outcome. It can easily accommodate and cultivate 3D human tissues, organoids or biopsies to suit every testing needs. MIVO® can be used as bioreactor, for enhancing tissues conditions and prolonging lifetime, for advanced drug testing assays on 3D tissues, for discovering new therapeutic approaches, and for basic research, without involving animal use. It is individually blistered, sterile, disposable, immediately ready-to-use.For more information visit:
www.react4life.com
Symrise is a global supplier of fragrances, flavors, food, nutrition and cosmetic ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, pharmaceuticals and producers of nutritional supplements and pet food. Its sales of € 3.5 billion in the 2020 fiscal year make Symrise a leading global provider. Headquartered in Holzminden, Germany, the Group is represented by more than 100 locations in Europe, Africa, the Middle East, Asia, the United States and Latin America. Symrise works with its clients to develop new ideas and market-ready concepts for products that form an integral part of everyday life. Economic success and corporate responsibility are inextricably linked as part of this process. In addition, Symrise has set up an animal testing policy in 2009 that aims to minimize such testing and Symrise is promoting alternative approaches wherever possible.


For more information visit:
www.symrise.com

Related content

March 9 – the last day to submit your abstracts for VPH2026 Conference in Milan!

This year, VPH 2026, organises the in silico toxicology track in collaboration with the European Society of Toxicology in Vitro ESTIV!

The Final ASPIS Open Symposium: From Innovation to Regulatory Impact

  • News

The Final ASPIS Open Symposium will take place on 2–3 July 2026 in Maastricht, the Netherlands, as a satellite event of the ESTIV 2026 Congress. This closing edition marks the culmination of five years of collaboration across the ASPIS cluster and shifts the focus firmly toward impact.

ESTIV/ASCCT Announcement on SOT: Qureator Hands-On Event March 22, 2026

The Physicians Committee for Responsible Medicine and Qureator are hosting a FREE in-person workshop and lab tour…

Silver Sponsor

Communication partners

Memorandum of Understanding